Defective Product Sales Cost GlaxoSmithKline $750 Million

An article published by the New York Times speaks of the $750 million settlement the British drug company GlaxoSmithKline has agreed to pay to end a number of civil and criminal complaints regarding knowingly defective medicines they put on store shelves for years. Such defective products include contaminated diaper cream, and an inaffective antidepressant. Twenty other medicines were sold with "questionable safety," including the diabetes drug Avandia, the heart drug Corteg, and the acid reflux drug Tagamet. The article goes on to say: "[New lawsuits] have asserted that drug makers misled patients and defrauded federal and state … [Read more...]

Bayer Warned by FDA for YAZ Testing Problems

The birth control Yasmin or Yaz has caused much controversy and concerns since it was first brought on the market back in March. Many people are concerned about the serious side effects of the pill and how Bayer seemed to have made these side effects not seem as serious as they are. Another thing that Bayer was warned about by the Food and Drug Administration or the FDA that they did not think was a serious problem was the testing of the quality of the pills. It measured the quality of its ingredients based on an average of several samples instead of reporting the individual test results of each sample like they should. Bayer then continued … [Read more...]